Clinical trial
A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin…
NCT00139659 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00139659 |
|---|---|
| Title | A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With Asthma |
| Official title | Efficacy and Safety of Inhaled Human Insulin (Exubera) Compared With Subcutaneous Human Insulin in the Therapy of Adult Subjects With Type 1 or Type 2 Diabetes Mellitus and Chronic Asthma: A One-Year, Multicenter, Randomized, Outpatient, Open-Label, Parallel-Group Comparative Trial |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma, Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Inhaled Insulin, Subcutaneous Insulin |
| Enrollment | 288 |
| Start date | Jan 1, 2003 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Aug 31, 2005 |
| Last update posted | Jun 2, 2010 |
| Countries | Brazil, Canada, Costa Rica, Germany, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: